Complete Guide to Semaglutide: Everything You Need to Know

Semaglutide is a prescription GLP-1 receptor agonist medication. FDA-approved versions (Wegovy, Ozempic) demonstrated significant weight loss in clinical trials. Important: Compounded semaglutide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications. Compounded semaglutide has not been studied in its own clinical trials. Individual results vary significantly. This article is for educational purposes only and is not medical advice; talk with a licensed healthcare provider about whether any treatment is right for you.

This comprehensive guide covers everything you need to know about semaglutide for weight loss, from how it works to what the clinical data shows, costs, side effects, and whether it’s right for you.

What Is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a type of medication that mimics the effects of a hormone your body naturally produces called GLP-1. This hormone plays a crucial role in regulating appetite, blood sugar levels, and how your body processes food.

The medication was initially developed and approved by the FDA for treating type 2 diabetes in 2017 under the brand name Ozempic. In 2021, a higher-dose version was approved specifically for chronic weight management under the brand name Wegovy (Source: FDA).

Brand Names and Forms

Semaglutide is available under several brand names:

• Ozempic: FDA-approved for type 2 diabetes, available in doses up to 2.0 mg weekly (injectable)
• Wegovy: FDA-approved for weight loss, available in doses up to 2.4 mg weekly (injectable)
• Rybelsus: FDA-approved for type 2 diabetes, oral tablet form taken daily
• Compounded Semaglutide: Prepared individually for a patient by a state-licensed 503A compounding pharmacy based on a prescription. Compounded semaglutide is NOT FDA-approved.

Learn more about the differences between brand-name and compounded options in our guide to semaglutide costs without insurance.

How Semaglutide Works for Weight Loss

Semaglutide promotes weight loss through multiple mechanisms that work together to reduce appetite and food intake:

1. Appetite Suppression

Semaglutide activates GLP-1 receptors in the brain, particularly in areas that control hunger and satiety. This significantly reduces appetite and food cravings, making it easier to eat less without feeling constantly hungry.

2. Delayed Gastric Emptying

The medication slows down how quickly food moves from your stomach to your small intestine. This creates a prolonged feeling of fullness after meals, helping you feel satisfied with smaller portions (Source: Diabetes Care Journal).

3. Blood Sugar Regulation

Semaglutide helps regulate blood sugar levels by stimulating insulin release when blood sugar is elevated and reducing glucagon secretion. This helps prevent the blood sugar spikes and crashes that can trigger hunger and cravings.

4. Energy Expenditure

Some research suggests that GLP-1 receptor agonists may slightly increase energy expenditure, though the primary mechanism of weight loss is through reduced caloric intake.

FDA Approval and Medical Uses

Type 2 Diabetes

Semaglutide was first approved by the FDA in December 2017 as Ozempic for improving blood sugar control in adults with type 2 diabetes. The oral form, Rybelsus, was approved for diabetes in 2019.

Chronic Weight Management

In June 2021, the FDA approved Wegovy (semaglutide 2.4 mg) for chronic weight management in adults with:

• Body Mass Index (BMI) of 30 kg/m² or greater (obesity), OR
• BMI of 27 kg/m² or greater (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

Cardiovascular Benefits

In March 2024, the FDA expanded Wegovy’s approval to include reducing the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight conditions (Source: FDA).

Note on compounded semaglutide: The FDA approvals and indications described above apply to the FDA-approved brand-name products (Wegovy, Ozempic, Rybelsus). They do not apply to compounded semaglutide, which is not FDA-approved and has not been evaluated by the FDA for any use.

Forms of Semaglutide: Injectable vs Oral

Semaglutide is available in two main forms, each with distinct advantages and considerations.

Injectable Semaglutide

Administration: Once-weekly subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm

Doses available:

• Ozempic: 0.25 mg, 0.5 mg, 1 mg, 2 mg
• Wegovy: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg
• Compounded: Strength prepared by the compounding pharmacy as directed by the prescriber

Effectiveness: Published clinical trial data is for FDA-approved brands only. Compounded semaglutide has not been studied in clinical trials, and these results should not be assumed to apply to it. Individual results vary.

Oral Semaglutide

Administration: Daily tablet taken on an empty stomach, 30 minutes before eating or drinking

Doses available: Rybelsus: 3 mg, 7 mg, 14 mg daily

Effectiveness: Clinical trials of FDA-approved oral semaglutide (Rybelsus) showed lower average weight loss than the injectable brands. These figures are from trials of the FDA-approved product; compounded oral semaglutide has not been studied in clinical trials.

Which Form Is Better?

The choice between injectable and oral semaglutide depends on your priorities:

Factor	Injectable	Oral
Clinical data	Trial data for FDA-approved brands	Lower trial weight loss vs. injectable brands
Convenience	Once weekly	Daily, strict timing requirements
Needle-free	No	Yes
Cost (brand-name)	$900-1,500/month	$900-1,000/month

The clinical figures above are from trials of FDA-approved products and do not apply to compounded semaglutide, which has not been studied in clinical trials. For a detailed comparison of the data, convenience, side effects, and costs, read our comprehensive guide to oral semaglutide vs injectable semaglutide.

Dosing and Administration

Important: Dosing is always directed by your prescribing clinician. The schedule below is the titration schedule from the FDA-approved Wegovy Prescribing Information, provided here for reference only. It is not dosing instructions for compounded semaglutide. Do not adjust your own dose. Follow the specific plan your clinician gives you.

FDA-Approved Wegovy Titration Schedule (for reference)

In the FDA-approved Wegovy product, the dose is gradually increased over 16-20 weeks to minimize side effects and allow the body to adjust:

Timeframe	Dose	Purpose
Weeks 1-4	0.25 mg weekly	Initiation - body adjustment
Weeks 5-8	0.5 mg weekly	First dose increase
Weeks 9-12	1 mg weekly	Second dose increase
Weeks 13-16	1.7 mg weekly	Third dose increase
Week 17+	2.4 mg weekly	Maintenance dose

Source: Wegovy Prescribing Information, FDA. Your clinician determines the right dose and schedule for you; it may differ from the above.

How to Inject Semaglutide

If your clinician prescribes an injectable, they and your pharmacy will give you instructions specific to your medication. General technique looks like this:

1. Choose your injection site: Abdomen (most common), front of thighs, or upper arm
2. Rotate injection sites: Use different locations each week to prevent skin irritation
3. Clean the area: Use an alcohol swab and let it dry completely
4. Inject: Follow the technique your clinician or pharmacy demonstrates for your specific product
5. Dispose properly: Place used needles in a sharps container

Oral Semaglutide Dosing

The FDA-approved oral product (Rybelsus) has strict administration requirements for proper absorption. Follow your clinician’s instructions:

• Take on an empty stomach: First thing in the morning before eating or drinking
• Use minimal water: Swallow whole with no more than 4 ounces of plain water
• Wait 30 minutes: Don’t eat, drink, or take other medications for at least 30 minutes
• Follow your clinician’s titration plan: Your prescriber determines your starting dose and any increases

How Effective Is Semaglutide?

Clinical Trial Results

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trials studied the FDA-approved brand product:

STEP 1 Trial Results (68 weeks, FDA-approved Wegovy, 2.4 mg weekly dose):

• Average weight loss: 14.9% of total body weight (about 33 pounds for a 220-pound person)
• 5% threshold: 86% of participants lost at least 5% of their body weight
• 10% threshold: 69% lost at least 10% of their body weight
• 15% threshold: 50% lost at least 15% of their body weight
• 20% threshold: 32% lost 20% or more of their body weight

Source: STEP 1 Clinical Trial, New England Journal of Medicine

These figures are from clinical trials of FDA-approved Wegovy. Compounded semaglutide has not been studied in clinical trials, and these results should not be assumed to apply to it.

For comparison within the same trial, the placebo group lost an average of only 2.4% of their body weight.

Real-World Data

Real-world studies of FDA-approved semaglutide report weight loss broadly consistent with the clinical trials when patients remain adherent. These observations are for the FDA-approved products, not compounded semaglutide, which has not been studied in clinical trials.

Factors Affecting Results

Individual results vary, and no specific outcome can be promised. Reported factors include:

• Starting weight: Higher starting weights often see greater absolute weight loss
• Dose reached: In the brand trials, the full 2.4 mg dose was associated with the largest average loss
• Adherence: Consistent weekly dosing as directed by your clinician
• Lifestyle factors: Diet quality and physical activity
• Genetics: Some individuals respond differently to GLP-1 medications
• Medical conditions: Underlying metabolic issues can affect response

Weight Loss Timeline: What to Expect

The pattern below is drawn from clinical trials of FDA-approved semaglutide. These figures are from trials of FDA-approved products. Compounded semaglutide has not been studied in clinical trials, and these results should not be assumed to apply to it. Individual results vary, and the doses listed reflect the FDA-approved Wegovy titration schedule for reference, not personal instructions. Your clinician sets your dose.

Month 1 (Weeks 1-4)

• Reference dose: 0.25 mg weekly (FDA-approved starter dose)
• Trial weight loss: roughly 2-5 pounds (1-2% of body weight)
• What people often notice: Reduced appetite, some nausea possible, eating less at meals

Month 2 (Weeks 5-8)

• Reference dose: 0.5 mg weekly
• Trial weight loss: roughly 5-10 pounds total (2-4% of body weight)
• What people often notice: More significant appetite reduction, side effects usually improving

Months 3-4 (Weeks 9-16)

• Reference dose: 1.0 mg, then 1.7 mg weekly
• Trial weight loss: roughly 10-20 pounds total (5-8% of body weight)
• What people often notice: Steady weight loss, clothes fitting differently, increased energy

Months 5-12

• Reference dose: 2.4 mg weekly (maintenance dose)
• Trial weight loss: roughly 20-35 pounds total (10-15% of body weight)
• What people often notice: Continued progress, possible plateaus, metabolic adaptations

Months 12-18+

• Reference dose: 2.4 mg weekly
• Trial weight loss: roughly 30-45+ pounds total (15-20% of body weight)
• What people often notice: Peak weight loss achieved, transition to maintenance mode

For a detailed week-by-week breakdown of what the clinical data shows, read our complete semaglutide weight loss timeline guide.

Side Effects and How to Manage Them

Like all medications, semaglutide can cause side effects. Most are mild to moderate, occur primarily during dose escalation, and improve over time. The frequencies below come from clinical trials of FDA-approved semaglutide.

Common Gastrointestinal Side Effects

Side Effect	Frequency	Typical Duration
Nausea	20-30% of users	2-4 weeks
Diarrhea	15-20% of users	1-3 weeks
Constipation	10-15% of users	Ongoing (manageable)
Vomiting	8-12% of users	1-2 weeks
Abdominal pain	5-10% of users	Variable

Source: STEP 1 Clinical Trial safety data, NEJM (FDA-approved semaglutide)

Quick Management Strategies

For Nausea:

• Eat smaller, more frequent meals
• Avoid fatty, greasy, or spicy foods
• Stay hydrated with small sips throughout the day
• Try ginger tea or ginger candies
• Don’t lie down immediately after eating

For Constipation:

• Increase fiber intake gradually (fruits, vegetables, whole grains)
• Drink at least 8 glasses of water daily
• Exercise regularly to stimulate digestion
• Consider a fiber supplement like psyllium
• Talk to your provider about stool softeners if needed

For Diarrhea:

• Avoid dairy products temporarily
• Eat bland, low-fiber foods (bananas, rice, applesauce, toast)
• Stay well-hydrated to replace lost fluids
• Limit caffeine and alcohol

Less Common Side Effects

• Fatigue or decreased energy (usually temporary)
• Headache
• Dizziness
• Increased heart rate (typically mild)
• Injection site reactions (redness, itching - injectable forms only)

Rare But Serious Side Effects

Contact your healthcare provider immediately if you experience:

• Severe abdominal pain: Could indicate pancreatitis (rare, approximately 0.1-0.2% of users) (Source: FDA Drug Safety Communication)
• Vision changes: Especially if you have diabetes (diabetic retinopathy risk)
• Rapid heartbeat or palpitations
• Signs of gallbladder problems: Pain in the upper right abdomen, fever, yellowing of skin or eyes
• Severe allergic reaction: Difficulty breathing, swelling of face or throat, severe rash
• Thoughts of self-harm or suicide

For comprehensive strategies to manage side effects, including dietary recommendations, supplement suggestions, and when to contact your doctor, read our complete guide to managing semaglutide side effects.

Safety Considerations

Who Should Not Use Semaglutide

Semaglutide is not appropriate for everyone. You should not use semaglutide if you have:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Previous serious allergic reaction to semaglutide
• Pregnancy or planning to become pregnant (semaglutide may harm the fetus)
• Breastfeeding (it’s unknown if semaglutide passes into breast milk)

Use with Caution If You Have:

• History of pancreatitis: Discuss risks and benefits with your provider
• Diabetic retinopathy: May worsen initially in people with diabetes
• Kidney disease: Dehydration from GI side effects can worsen kidney function
• History of depression or suicidal thoughts: Monitor mental health closely
• Gallbladder disease: Rapid weight loss can increase gallstone risk

Drug Interactions

Semaglutide can interact with other medications:

• Insulin and other diabetes medications: May increase risk of low blood sugar (hypoglycemia). Your provider will likely reduce doses of these medications.
• Oral medications: Delayed gastric emptying may affect absorption. Take oral medications at least 1 hour before semaglutide injection.
• Warfarin: May require closer monitoring of INR levels

Always inform your healthcare provider about all medications, supplements, and herbal products you’re taking.

Long-Term Safety

The semaglutide molecule has an established safety profile in FDA-approved products, which have been studied for up to 2 years in clinical trials. Compounded versions have not undergone the same FDA review and have not been studied in clinical trials. As a relatively new class of weight-loss medication, very long-term effects (5+ years) of semaglutide are still being evaluated through ongoing research.

For detailed information about compounded semaglutide specifically, including how state-licensed compounding pharmacies operate, read our guide to compounded semaglutide safety.

Cost and Insurance Coverage

Brand-Name Costs

Without insurance, brand-name semaglutide is expensive:

• Wegovy: $1,349-$1,595 per month at retail pharmacies
• Ozempic: $900-$1,000 per month (when used off-label for weight loss)
• Rybelsus: $900-$1,000 per month

Insurance Coverage

Insurance coverage varies significantly:

• For diabetes: Most insurance plans cover Ozempic for type 2 diabetes, though copays vary from $25-$500/month
• For weight loss: Coverage for Wegovy is limited. Many insurers exclude weight loss medications entirely or require extensive documentation and prior authorization
• Medicare: Does not currently cover weight loss medications, including Wegovy

Compounded Semaglutide

Compounded semaglutide, prepared by a state-licensed 503A compounding pharmacy, is often less expensive than brand-name products. For compounded options, keep these points in mind:

• Monthly cost: Generally lower than brand-name; pricing varies by provider
• FDA Status: Compounded semaglutide is NOT FDA-approved and has not been studied in clinical trials
• Prescription-based: Prepared individually for you based on your prescription
• Insurance: Typically not covered, but the out-of-pocket cost is often lower than brand-name

For our compounded semaglutide program, please see current pricing on our product page. Medical supervision is included.

Annual Cost Comparison (brand-name reference)

Option	Monthly Cost	Annual Cost
Wegovy (brand-name)	$1,349-$1,595	$16,188-$19,140
Ozempic (off-label)	$900-$1,000	$10,800-$12,000
Compounded semaglutide	See current pricing on our product page	Varies by provider

For a complete breakdown of pricing, hidden costs, discount programs, and strategies to save, read our comprehensive guide to semaglutide costs without insurance.

Who Should Use Semaglutide?

FDA-Approved Indications

Semaglutide for weight loss (the FDA-approved Wegovy product) is indicated for adults with:

• BMI ≥ 30 kg/m² (obesity), OR
• BMI ≥ 27 kg/m² (overweight) with at least one weight-related comorbidity such as:
  • High blood pressure (hypertension)
  • Type 2 diabetes
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea
  • Cardiovascular disease

Who May Be a Candidate

A clinician may consider semaglutide for people who:

• Have struggled with traditional weight loss methods: Diet and exercise alone haven’t produced sustainable results
• Are committed to lifestyle changes: Willing to make dietary improvements and increase physical activity
• Need significant weight loss: Have a meaningful amount to lose for health improvement
• Have weight-related health issues: Conditions that may improve with weight loss
• Are prepared for long-term treatment: GLP-1 therapy is typically ongoing (often 1-2 years or more)
• Don’t have contraindications: No history of MTC, MEN 2, or other exclusion criteria

When Semaglutide May Not Be the Best Choice

• Looking for a quick fix: Semaglutide requires gradual dose escalation and long-term commitment
• Only need to lose 5-10 pounds: Generally reserved for people needing more significant weight loss
• Have contraindications: Family history of MTC, MEN 2, pregnancy, or other exclusion criteria
• Unwilling to make lifestyle changes: Medication works best combined with diet and exercise improvements
• Can’t commit to ongoing treatment: Weight regain is common if medication is stopped

Alternatives to Semaglutide

Other GLP-1 Medications

Tirzepatide (Mounjaro, Zepbound):

• Type: Dual GLP-1 and GIP receptor agonist
• Clinical data: Trial data is for FDA-approved brands; compounded versions have not been studied in clinical trials; individual results vary
• Dosing: Once-weekly injection, clinician-directed
• Cost: Brand-name typically $1,000-$1,600/month

For a detailed head-to-head comparison of the clinical data, side effects, cost, and which medication might be right for you, read our complete tirzepatide vs semaglutide comparison.

Liraglutide (Saxenda, Victoza):

• Type: Earlier GLP-1 medication
• Clinical data: Lower average weight loss in trials than semaglutide (5-10%)
• Dosing: Daily injection (less convenient)
• Cost: $1,000-$1,400/month

Non-GLP-1 Weight Loss Medications

• Phentermine-topiramate (Qsymia): Appetite suppressant, 8-10% weight loss in trials, oral daily medication
• Naltrexone-bupropion (Contrave): Reduces cravings, 5-8% weight loss in trials, oral twice daily
• Orlistat (Xenical, Alli): Blocks fat absorption, 3-5% weight loss in trials, oral with meals

Non-Medication Approaches

• Bariatric surgery: Most effective for severe obesity (25-30% weight loss), but invasive with surgical risks
• Intensive lifestyle intervention: Structured programs with meal replacement, coaching, and behavioral therapy can achieve 5-10% weight loss
• Very low-calorie diets: Medically supervised programs (800-1,000 calories/day) can produce rapid initial weight loss

How to Get Started with Semaglutide

Step 1: Consult a Healthcare Provider

You’ll need a prescription from a licensed healthcare provider. Options include:

• Your primary care physician: Can prescribe if experienced with weight management
• Obesity medicine specialist: Specialized expertise in weight loss medications
• Endocrinologist: Hormone specialists familiar with GLP-1 medications
• Telehealth services: Convenient online consultations with licensed providers

During your consultation, your provider will:

• Review your medical history and current medications
• Calculate your BMI and assess weight-related health conditions
• Discuss your weight loss goals and previous attempts
• Explain how semaglutide works, potential side effects, and what to expect
• Determine if you’re a good candidate
• Write a prescription if appropriate, and direct your dosing plan

Step 2: Choose Your Pharmacy Option

Brand-name from retail pharmacy:

• Standard pharmacies (CVS, Walgreens, etc.)
• Submit insurance for potential coverage
• Use manufacturer savings cards if eligible (up to $500-$650/month off)
• Most expensive option without insurance

Compounded from a state-licensed 503A compounding pharmacy:

• A state-licensed 503A compounding pharmacy prepares your medication individually, for you, based on your prescription
• Compounded semaglutide is NOT FDA-approved and has not been studied in clinical trials
• Note: a pharmacy may be “FDA-registered,” but FDA registration is not the same as FDA approval of the medication
• Typically includes medical oversight
• Our compounded semaglutide program includes provider consultations, medication, and ongoing support

Step 3: Start Treatment and Monitor Progress

First injection:

• Your clinician determines your starting dose and schedule
• Choose your preferred injection day and stick to it
• Follow proper injection technique as demonstrated for your product
• Track your first dose and any side effects

Ongoing monitoring:

• Weekly injections on the same day, as prescribed
• Monthly weight checks and measurements
• Regular follow-ups with your provider (every 4-8 weeks initially)
• Blood work as recommended (especially if you have diabetes)
• Dose adjustments directed by your clinician as tolerated

Lifestyle optimization:

• Focus on protein-rich foods (helps preserve muscle during weight loss)
• Stay well-hydrated (at least 64 oz water daily)
• Incorporate regular physical activity (150 minutes/week minimum)
• Practice portion control and mindful eating
• Track your food intake and progress

Step 4: Plan for Long-Term Maintenance

Weight loss with semaglutide typically occurs over many months. After reaching your goal weight:

• Continue medication as directed: Most people need ongoing treatment to maintain weight loss
• Possible dose adjustment: Your clinician may adjust your maintenance dose
• Strengthen habits: Use the weight loss period to establish sustainable healthy habits
• Regular monitoring: Continue follow-ups even after reaching goal weight

Research shows that discontinuing semaglutide often leads to weight regain, so plan for long-term treatment (1-2+ years minimum).

Related reading: Curious why some people use lower, personalized doses? Read Microdosing Semaglutide: The Honest Guide to Low-Dose, Personalized GLP-1 Care.

Frequently Asked Questions

How fast does semaglutide work?

In clinical trials of FDA-approved semaglutide, most people noticed reduced appetite within the first week, with weight loss beginning in the first month and continuing over many months. These figures are from trials of FDA-approved products; compounded semaglutide has not been studied in clinical trials, and individual results vary. See our detailed timeline guide.

Do I need to diet and exercise on semaglutide?

While semaglutide suppresses appetite and helps you eat less naturally, combining it with a healthy diet and regular exercise produces the best results. Clinical trials included lifestyle intervention alongside medication. Think of semaglutide as a tool that makes healthy choices easier, not a replacement for them.

What happens if I stop taking semaglutide?

Most people regain weight after stopping semaglutide. Clinical trials of the FDA-approved product show meaningful weight regain within a year of stopping. This doesn’t mean the medication “failed” - it means obesity is a chronic condition often requiring ongoing management, similar to medications for high blood pressure or cholesterol.

Can I drink alcohol on semaglutide?

Moderate alcohol consumption is generally considered acceptable with semaglutide, but many people find their tolerance decreases. Alcohol on an empty stomach or in combination with semaglutide’s effects can increase nausea. Some people also experience reduced desire for alcohol while on the medication. Discuss your situation with your provider.

Is semaglutide safe?

The semaglutide molecule has an established safety profile in FDA-approved products, which have been studied extensively and used by millions of people. Compounded versions have not undergone the same FDA review and have not been studied in clinical trials. The most common side effects are gastrointestinal and usually mild. Rare serious side effects include pancreatitis (0.1-0.2%) and gallbladder issues. It’s contraindicated for people with a personal or family history of medullary thyroid cancer (MTC) or MEN 2. Read our safety guide for more details.

How much does semaglutide cost?

Brand-name Wegovy costs $1,349-$1,595/month without insurance. For compounded semaglutide pricing, please see current pricing on our product page. Insurance coverage for weight loss is limited, but coverage for diabetes (Ozempic) is more common. See our complete cost breakdown.

Is compounded semaglutide the same as Wegovy?

No. Compounded semaglutide is NOT FDA-approved and has not been studied in its own clinical trials. The FDA does not verify the safety or effectiveness of compounded medications. It is prepared individually for a patient by a state-licensed 503A compounding pharmacy based on a prescription. It should not be assumed to be equivalent to, or to produce the same results as, FDA-approved Wegovy or Ozempic. For a detailed explanation of the regulatory status, see our guide on compounded semaglutide FDA approval. Individual results vary significantly.

What’s the difference between Ozempic and Wegovy?

Both contain semaglutide, but Wegovy is FDA-approved specifically for weight loss and goes up to 2.4 mg weekly, while Ozempic is approved for diabetes and goes up to 2.0 mg weekly. They are the same active molecule at different approved doses and in different pens. Many people use Ozempic off-label for weight loss.

Which is better: semaglutide or tirzepatide?

Clinical trial data exists for the FDA-approved versions of these medications only; compounded versions have not been studied in clinical trials. Both tirzepatide and semaglutide are GLP-1-based medications. Individual results vary significantly. Read our detailed comparison.

Can I take semaglutide if I don’t have diabetes?

Yes. The FDA-approved Wegovy product is indicated for weight loss in people without diabetes who have a BMI ≥30 or BMI ≥27 with weight-related health conditions. You don’t need diabetes to be a candidate for semaglutide for weight management.

Will semaglutide cause muscle loss?

Any significant weight loss includes some muscle loss along with fat loss. On average, a meaningful portion of weight lost on semaglutide can be lean mass. You can help minimize muscle loss by eating adequate protein (0.7-1 gram per pound of body weight), doing resistance training 2-3 times weekly, and losing weight gradually.

Can I get pregnant while taking semaglutide?

No. Semaglutide may harm a developing fetus and should be stopped at least 2 months before attempting pregnancy. Women of childbearing age should use reliable contraception while on semaglutide. If you become pregnant while taking semaglutide, stop immediately and contact your healthcare provider.

Is there a pill form of semaglutide?

Yes, Rybelsus is an FDA-approved oral tablet form of semaglutide. It requires daily dosing with strict timing. Clinical trial data for the FDA-approved oral product differs from the injectable forms; compounded oral semaglutide has not been studied in clinical trials. See our oral vs injectable comparison.

Conclusion: Is Semaglutide Right for You?

FDA-approved semaglutide medications (Wegovy, Ozempic) demonstrated significant results in clinical trials. Important: Compounded semaglutide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications, and compounded semaglutide has not been studied in clinical trials. The clinical figures throughout this article are from trials of FDA-approved products and should not be assumed to apply to compounded semaglutide. Individual results vary significantly based on adherence, diet, and exercise.

Semaglutide may be worth discussing with your clinician if you:

• Have struggled to lose weight or maintain weight loss with diet and exercise alone
• Have a BMI ≥30 or BMI ≥27 with weight-related health conditions
• Are committed to long-term treatment (1-2+ years)
• Can combine medication with lifestyle improvements
• Don’t have contraindications like a personal or family history of medullary thyroid cancer (MTC) or MEN 2

Ready to get started?

Our program connects you with a licensed provider who evaluates whether treatment is appropriate for you and directs your dosing. If a compounded medication is prescribed, it is prepared individually for you by a state-licensed 503A compounding pharmacy based on your prescription. Compounded semaglutide is NOT FDA-approved.

• Initial medical consultation with a licensed provider
• Clinician-directed prescription and dosing plan
• Medication prepared individually for you by a state-licensed 503A compounding pharmacy (if prescribed)
• Injection supplies and detailed instructions
• Ongoing medical support and clinician-directed dose adjustments
• No hidden fees or long-term contracts

For pricing, please see current pricing on our product page. For those preferring oral medication, our oral semaglutide option provides a needle-free alternative.

Have questions? Schedule a free consultation with one of our obesity medicine specialists to discuss whether semaglutide is right for your weight loss goals.